6jxr › Citations

Structural basis of assembly of the human T cell receptor-CD3 complex.

Zheng L, Lin J, Zhang B, Zhu Y, Li N, Xie S, Wang Y, Gao N, Huang Z
Nature 573 546-552 (2019)
Cited: 127 times
EuropePMC logo PMID: 31461748

Abstract

The αβ T cell receptor (TCR), in association with the CD3γε-CD3δε-CD3ζζ signalling hexamer, is the primary determinant of T cell development and activation, and of immune responses to foreign antigens. The mechanism of assembly of the TCR-CD3 complex remains unknown. Here we report a cryo-electron microscopy structure of human TCRαβ in complex with the CD3 hexamer at 3.7 Å resolution. The structure contains the complete extracellular domains and all the transmembrane helices of TCR-CD3. The octameric TCR-CD3 complex is assembled with 1:1:1:1 stoichiometry of TCRαβ:CD3γε:CD3δε:CD3ζζ. Assembly of the extracellular domains of TCR-CD3 is mediated by the constant domains and connecting peptides of TCRαβ that pack against CD3γε-CD3δε, forming a trimer-like structure proximal to the plasma membrane. The transmembrane segment of the CD3 complex adopts a barrel-like structure formed by interaction of the two transmembrane helices of CD3ζζ with those of CD3γε and CD3δε. Insertion of the transmembrane helices of TCRαβ into the barrel-like structure via both hydrophobic and ionic interactions results in transmembrane assembly of the TCR-CD3 complex. Together, our data reveal the structural basis for TCR-CD3 complex assembly, providing clues to TCR triggering and a foundation for rational design of immunotherapies that target the complex.

Reviews - 6jxr mentioned but not cited (6)

  1. 50 Years of structural immunology. Wilson IA, Stanfield RL. J Biol Chem 296 100745 (2021)
  2. Structural understanding of T cell receptor triggering. Xu X, Li H, Xu C. Cell Mol Immunol 17 193-202 (2020)
  3. Cryo-electron Microscopic Analysis of Single-Pass Transmembrane Receptors. Cai K, Zhang X, Bai XC. Chem Rev 122 13952-13988 (2022)
  4. Coreceptors and TCR Signaling - the Strong and the Weak of It. Mørch AM, Bálint Š, Santos AM, Davis SJ, Dustin ML. Front Cell Dev Biol 8 597627 (2020)
  5. Immune Checkpoint Receptors Signaling in T Cells. Baldanzi G. Int J Mol Sci 23 3529 (2022)
  6. The structural basis of T-cell receptor (TCR) activation: An enduring enigma. Mariuzza RA, Agnihotri P, Orban J. J. Biol. Chem. 295 914-925 (2020)

Articles - 6jxr mentioned but not cited (25)

  1. Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells. Singh N, Frey NV, Engels B, Barrett DM, Shestova O, Ravikumar P, Cummins KD, Lee YG, Pajarillo R, Chun I, Shyu A, Highfill SL, Price A, Zhao L, Peng L, Granda B, Ramones M, Lu XM, Christian DA, Perazzelli J, Lacey SF, Roy NH, Burkhardt JK, Colomb F, Damra M, Abdel-Mohsen M, Liu T, Liu D, Standley DM, Young RM, Brogdon JL, Grupp SA, June CH, Maude SL, Gill S, Ruella M. Nat Med 27 842-850 (2021)
  2. CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells. Kluesner MG, Lahr WS, Lonetree CL, Smeester BA, Qiu X, Slipek NJ, Claudio Vázquez PN, Pitzen SP, Pomeroy EJ, Vignes MJ, Lee SC, Bingea SP, Andrew AA, Webber BR, Moriarity BS. Nat Commun 12 2437 (2021)
  3. Small molecule AX-024 reduces T cell proliferation independently of CD3ϵ/Nck1 interaction, which is governed by a domain swap in the Nck1-SH3.1 domain. Richter K, Rufer AC, Muller M, Burger D, Casagrande F, Grossenbacher T, Huber S, Hug MN, Koldewey P, D'Osualdo A, Schlatter D, Stoll T, Rudolph MG. J Biol Chem 295 7849-7864 (2020)
  4. Allosteric activation of T cell antigen receptor signaling by quaternary structure relaxation. Lanz AL, Masi G, Porciello N, Cohnen A, Cipria D, Prakaash D, Bálint Š, Raggiaschi R, Galgano D, Cole DK, Lepore M, Dushek O, Dustin ML, Sansom MSP, Kalli AC, Acuto O. Cell Rep 36 109375 (2021)
  5. Height, but not binding epitope, affects the potency of synthetic TCR agonists. Wilhelm KB, Morita S, McAffee DB, Kim S, O'Dair MK, Groves JT. Biophys J 120 3869-3880 (2021)
  6. Genetic mapping and candidate gene analysis for melon resistance to Phytophthora capsici. Wang P, Xu X, Zhao G, He Y, Hou C, Kong W, Zhang J, Liu S, Xu Y, Xu Z. Sci Rep 10 20456 (2020)
  7. Multi-scale simulations of the T cell receptor reveal its lipid interactions, dynamics and the arrangement of its cytoplasmic region. Prakaash D, Cook GP, Acuto O, Kalli AC. PLoS Comput Biol 17 e1009232 (2021)
  8. Peptide-MHC Binding Reveals Conserved Allosteric Sites in MHC Class I- and Class II-Restricted T Cell Receptors (TCRs). He Y, Agnihotri P, Rangarajan S, Chen Y, Kerzic MC, Ma B, Nussinov R, Mariuzza RA, Orban J. J Mol Biol 432 166697 (2020)
  9. Structural variability and concerted motions of the T cell receptor - CD3 complex. Pandey PR, Różycki B, Lipowsky R, Weikl TR. Elife 10 e67195 (2021)
  10. The kinase occupancy of T cell coreceptors reconsidered. Mørch AM, Schneider F, Jenkins E, Santos AM, Fraser SE, Davis SJ, Dustin ML. Proc Natl Acad Sci U S A 119 e2213538119 (2022)
  11. A class-mismatched TCR bypasses MHC restriction via an unorthodox but fully functional binding geometry. Singh NK, Alonso JA, Devlin JR, Keller GLJ, Gray GI, Chiranjivi AK, Foote SG, Landau LM, Arbuiso AG, Weiss LI, Rosenberg AM, Hellman LM, Nishimura MI, Baker BM. Nat Commun 13 7189 (2022)
  12. A structural platform for B cell receptor signaling. Xie W, Wucherpfennig K, Patel DJ. Cell Res (2022)
  13. Allosteric inhibition of the T cell receptor by a designed membrane ligand. Ye Y, Morita S, Chang JJ, Buckley PM, Wilhelm KB, DiMaio D, Groves JT, Barrera FN. Elife 12 e82861 (2023)
  14. Bivalent binding of staphylococcal superantigens to the TCR and CD28 triggers inflammatory signals independently of antigen presenting cells. Kunkl M, Amormino C, Spallotta F, Caristi S, Fiorillo MT, Paiardini A, Kaempfer R, Tuosto L. Front Immunol 14 1170821 (2023)
  15. Catch bond models may explain how force amplifies TCR signaling and antigen discrimination. Choi HK, Cong P, Ge C, Natarajan A, Liu B, Zhang Y, Li K, Rushdi MN, Chen W, Lou J, Krogsgaard M, Zhu C. Nat Commun 14 2616 (2023)
  16. Conformation-selective rather than avidity-based binding to tumor associated antigen derived peptide-MHC enables targeting of WT1-pMHC low expressing cancer cells by anti-WT1-pMHC/CD3 T cell engagers. Walseng E, Wang B, Yang C, Patel P, Zhao C, Zhang H, Zhao P, Mazor Y. Front Immunol 14 1275304 (2023)
  17. Innate TCRβ-chain engagement drives human T cells toward distinct memory-like effector phenotypes with immunotherapeutic potentials. Vantourout P, Eum J, Conde Poole M, Hayday TS, Laing AG, Hussain K, Nuamah R, Kannambath S, Moisan J, Stoop A, Battaglia S, Servattalab R, Hsu J, Bayliffe A, Katragadda M, Hayday AC. Sci Adv 9 eadj6174 (2023)
  18. Intrinsic Disorder in the T Cell Receptor Creates Cooperativity and Controls ZAP70 Binding. Clemens L, Dushek O, Allard J. Biophys J 120 379-392 (2021)
  19. research-article Leveraging IFNγ/CD38 regulation to unmask and target leukemia stem cells in acute myelogenous leukemia. Murtadha M, Park M, Zhu Y, Caserta E, Dona AA, Singer M, Vahed H, Tasndoh T, Gonzalez A, Ly K, Sanchez JF, Chowdhury A, Pozhitkov A, Ghoda L, Li L, Zhang B, Krishnan A, Marcucci G, Williams J, Pichiorri F. bioRxiv 2023.02.27.530273 (2023)
  20. Robust T cell activation requires an eIF3-driven burst in T cell receptor translation. De Silva D, Ferguson L, Chin GH, Smith BE, Apathy RA, Roth TL, Blaeschke F, Kudla M, Marson A, Ingolia NT, Cate JH. Elife 10 e74272 (2021)
  21. Structural analysis of cancer-relevant TCR-CD3 and peptide-MHC complexes by cryoEM. Saotome K, Dudgeon D, Colotti K, Moore MJ, Jones J, Zhou Y, Rafique A, Yancopoulos GD, Murphy AJ, Lin JC, Olson WC, Franklin MC. Nat Commun 14 2401 (2023)
  22. Structural principles of B cell antigen receptor assembly. Dong Y, Pi X, Bartels-Burgahn F, Saltukoglu D, Liang Z, Yang J, Alt FW, Reth M, Wu H. Nature 612 156-161 (2022)
  23. Structure of a fully assembled tumor-specific T cell receptor ligated by pMHC. Sušac L, Vuong MT, Thomas C, von Bülow S, O'Brien-Ball C, Santos AM, Fernandes RA, Hummer G, Tampé R, Davis SJ. Cell 185 3201-3213.e19 (2022)
  24. T cell and B cell antigen receptors share a conserved core transmembrane structure. Ramesh S, Park S, Im W, Call MJ, Call ME. Proc Natl Acad Sci U S A 119 e2208058119 (2022)
  25. The Full Model of the pMHC-TCR-CD3 Complex: A Structural and Dynamical Characterization of Bound and Unbound States. Alba J, D'Abramo M. Cells 11 668 (2022)


Reviews citing this publication (36)

  1. ApoB-Specific CD4+ T Cells in Mouse and Human Atherosclerosis. Marchini T, Hansen S, Wolf D. Cells 10 446 (2021)
  2. Non-Alcoholic Steatohepatitis (NASH) - A Review of a Crowded Clinical Landscape, Driven by a Complex Disease. Fraile JM, Palliyil S, Barelle C, Porter AJ, Kovaleva M. Drug Des Devel Ther 15 3997-4009 (2021)
  3. The role of endocytic trafficking in antigen T cell receptor activation. Evnouchidou I, Caillens V, Koumantou D, Saveanu L. Biomed J 45 310-320 (2022)
  4. Cancer Nanopharmaceuticals: Physicochemical Characterization and In Vitro/In Vivo Applications. Zielińska A, Szalata M, Gorczyński A, Karczewski J, Eder P, Severino P, Cabeda JM, Souto EB, Słomski R. Cancers (Basel) 13 1896 (2021)
  5. T cell receptor (TCR) signaling in health and disease. Shah K, Al-Haidari A, Sun J, Kazi JU. Signal Transduct Target Ther 6 412 (2021)
  6. The Adjuvant Effects on Vaccine and the Immunomodulatory Mechanisms of Polysaccharides From Traditional Chinese Medicine. Wang D, Liu Y, Zhao W. Front Mol Biosci 8 655570 (2021)
  7. Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy. García-Díaz N, Piris MÁ, Ortiz-Romero PL, Vaqué JP. Cancers (Basel) 13 1931 (2021)
  8. Clinical, Diagnostic and Prognostic Characteristics of Primary Cutaneous Gamma Delta T-cell Lymphomas. Muhsen IN, El Fakih R, Hamadani M, Lazarus HM, Kharfan-Dabaja MA, Aljurf M. Clin Hematol Int 4 1-10 (2022)
  9. Developments, applications, and prospects of cryo-electron microscopy. Benjin X, Ling L. Protein Sci. 29 872-882 (2020)
  10. T Cell Activation Machinery: Form and Function in Natural and Engineered Immune Receptors. Chandler NJ, Call MJ, Call ME. Int J Mol Sci 21 E7424 (2020)
  11. A Story of Kinases and Adaptors: The Role of Lck, ZAP-70 and LAT in Switch Panel Governing T-Cell Development and Activation. Fernández-Aguilar LM, Vico-Barranco I, Arbulo-Echevarria MM, Aguado E. Biology (Basel) 12 1163 (2023)
  12. Ab locks for improving the selectivity and safety of antibody drugs. Lin WW, Lu YC, Chuang CH, Cheng TL. J. Biomed. Sci. 27 76 (2020)
  13. CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation. Guo F, Cui J. Cancers (Basel) 13 1955 (2021)
  14. CARs: Beyond T Cells and T Cell-Derived Signaling Domains. Sievers NM, Dörrie J, Schaft N. Int J Mol Sci 21 (2020)
  15. Considerations of Antibody Geometric Constraints on NK Cell Antibody Dependent Cellular Cytotoxicity. Murin CD. Front Immunol 11 1635 (2020)
  16. Current Progress of CAR-NK Therapy in Cancer Treatment. Pang Z, Wang Z, Li F, Feng C, Mu X. Cancers (Basel) 14 4318 (2022)
  17. Direct Regulation of the T Cell Antigen Receptor's Activity by Cholesterol. Pathan-Chhatbar S, Drechsler C, Richter K, Morath A, Wu W, OuYang B, Xu C, Schamel WW. Front Cell Dev Biol 8 615996 (2020)
  18. HSP70 Multi-Functionality in Cancer. Albakova Z, Armeev GA, Kanevskiy LM, Kovalenko EI, Sapozhnikov AM. Cells 9 (2020)
  19. Harnessing αβ T cell receptor mechanobiology to achieve the promise of immuno-oncology. Reinherz EL, Hwang W, Lang MJ. Proc Natl Acad Sci U S A 120 e2215694120 (2023)
  20. Immune Response and Immune Checkpoint Molecules in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Review. Koukourakis IM, Platoni K, Tiniakos D, Kouloulias V, Zygogianni A. Curr Issues Mol Biol 45 4495-4517 (2023)
  21. Mechanotransduction in T Cell Development, Differentiation and Function. Rushdi M, Li K, Yuan Z, Travaglino S, Grakoui A, Zhu C. Cells 9 (2020)
  22. Membrane protein trafficking in the anti-tumor immune response: work of endosomal-lysosomal system. Jin Y, Deng Z, Zhu T. Cancer Cell Int 22 413 (2022)
  23. Modulating T Cell Responses by Targeting CD3. Menon AP, Moreno B, Meraviglia-Crivelli D, Nonatelli F, Villanueva H, Barainka M, Zheleva A, van Santen HM, Pastor F. Cancers (Basel) 15 1189 (2023)
  24. Naturally Occurring Genetic Alterations in Proximal TCR Signaling and Implications for Cancer Immunotherapy. Kent A, Longino NV, Christians A, Davila E. Front Immunol 12 658611 (2021)
  25. Promise and challenges of clinical non-invasive T-cell tracking in the era of cancer immunotherapy. Gosmann D, Russelli L, Weber WA, Schwaiger M, Krackhardt AM, D'Alessandria C. EJNMMI Res 12 5 (2022)
  26. Recent advances in understanding TCR signaling: a synaptic perspective. Dustin ML. Fac Rev 12 25 (2023)
  27. Regulating the discriminatory response to antigen by T-cell receptor. Gangopadhyay K, Roy S, Sen Gupta S, Chandradasan AC, Chowdhury S, Das R. Biosci Rep 42 BSR20212012 (2022)
  28. Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity. Burnell SEA, Capitani L, MacLachlan BJ, Mason GH, Gallimore AM, Godkin A. Immunother Adv 2 ltab025 (2022)
  29. T-cell repertoire diversity: friend or foe for protective antitumor response? Porciello N, Franzese O, D'Ambrosio L, Palermo B, Nisticò P. J Exp Clin Cancer Res 41 356 (2022)
  30. TCR Pathway Mutations in Mature T Cell Lymphomas. Zhang Y, Cheng K, Choi J. J Immunol 211 1450-1458 (2023)
  31. TCR Recognition of Peptide-MHC-I: Rule Makers and Breakers. Szeto C, Lobos CA, Nguyen AT, Gras S. Int J Mol Sci 22 (2020)
  32. The Enigmatic Nature of the TCR-pMHC Interaction: Implications for CAR-T and TCR-T Engineering. Shevyrev DV, Tereshchenko VP, Sennikov SV. Int J Mol Sci 23 14728 (2022)
  33. The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients. Arnaud M, Bobisse S, Chiffelle J, Harari A. Front Immunol 12 701636 (2021)
  34. The interplay between membrane topology and mechanical forces in regulating T cell receptor activity. Al-Aghbar MA, Jainarayanan AK, Dustin ML, Roffler SR. Commun Biol 5 40 (2022)
  35. The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells. Li J, Xiao Z, Wang D, Jia L, Nie S, Zeng X, Hu W. Mol Cancer 22 141 (2023)
  36. What's the Catch? The Significance of Catch Bonds in T Cell Activation. Faust MA, Rasé VJ, Lamb TJ, Evavold BD. J Immunol 211 333-342 (2023)

Articles citing this publication (60)

  1. The clinical course and its correlated immune status in COVID-19 pneumonia. He R, Lu Z, Zhang L, Fan T, Xiong R, Shen X, Feng H, Meng H, Lin W, Jiang W, Geng Q. J. Clin. Virol. 127 104361 (2020)
  2. Functional Domain Order of an Anti-EGFR × Anti-CD16 Bispecific Diabody Involving NK Cell Activation. Kuwahara A, Nagai K, Nakanishi T, Kumagai I, Asano R. Int J Mol Sci 21 E8914 (2020)
  3. An Engineered T Cell Receptor Variant Realizes the Limits of Functional Binding Modes. Singh NK, Alonso JA, Harris DT, Anderson SD, Ma J, Hellman LM, Rosenberg AM, Kolawole EM, Evavold BD, Kranz DM, Baker BM. Biochemistry 59 4163-4175 (2020)
  4. DNA origami patterning of synthetic T cell receptors reveals spatial control of the sensitivity and kinetics of signal activation. Dong R, Aksel T, Chan W, Germain RN, Vale RD, Douglas SM. Proc Natl Acad Sci U S A 118 e2109057118 (2021)
  5. Defining and Studying B Cell Receptor and TCR Interactions. Rappazzo CG, Fernández-Quintero ML, Mayer A, Wu NC, Greiff V, Guthmiller JJ. J Immunol 211 311-322 (2023)
  6. Using molecular dynamics simulations to interrogate T cell receptor non-equilibrium kinetics. Rollins ZA, Faller R, George SC. Comput Struct Biotechnol J 20 2124-2133 (2022)
  7. A general chemical crosslinking strategy for structural analyses of weakly interacting proteins applied to preTCR-pMHC complexes. Mizsei R, Li X, Chen WN, Szabo M, Wang JH, Wagner G, Reinherz EL, Mallis RJ. J Biol Chem 296 100255 (2021)
  8. An association between immune status and chest CT scores in COVID-19 patients. Çölkesen F, Poyraz N, Arslan Ş, Yılmaz PD, Kepenek Kurt E, Korkmaz C, Yıldız E, Çölkesen F, Aytekin G, Keleş S, Reisli İ. Int J Clin Pract 75 e14767 (2021)
  9. Cooperative binding of T cell receptor and CD4 to peptide-MHC enhances antigen sensitivity. Rushdi MN, Pan V, Li K, Choi HK, Travaglino S, Hong J, Griffitts F, Agnihotri P, Mariuzza RA, Ke Y, Zhu C. Nat Commun 13 7055 (2022)
  10. De novo-designed transmembrane domains tune engineered receptor functions. Elazar A, Chandler NJ, Davey AS, Weinstein JY, Nguyen JV, Trenker R, Cross RS, Jenkins MR, Call MJ, Call ME, Fleishman SJ. Elife 11 e75660 (2022)
  11. Nanoparticle-Mediated Lipid Metabolic Reprogramming of T Cells in Tumor Microenvironments for Immunometabolic Therapy. Kim D, Wu Y, Li Q, Oh YK. Nanomicro Lett 13 31 (2021)
  12. Single-molecule investigations of T-cell activation. Kaitao L, William R, Zhou Y, Cheng Z. Curr Opin Biomed Eng 12 102-110 (2019)
  13. Structural and Biophysical Insights into the TCRαβ Complex in Chickens. Zhang L, Liu Y, Meng G, Liang R, Zhang B, Xia C. iScience 23 101828 (2020)
  14. The αβTCR mechanosensor exploits dynamic ectodomain allostery to optimize its ligand recognition site. Hwang W, Mallis RJ, Lang MJ, Reinherz EL. Proc Natl Acad Sci U S A 117 21336-21345 (2020)
  15. huARdb: human Antigen Receptor database for interactive clonotype-transcriptome analysis at the single-cell level. Wu L, Xue Z, Jin S, Zhang J, Guo Y, Bai Y, Jin X, Wang C, Wang L, Liu Z, Wang JQ, Lu L, Liu W. Nucleic Acids Res 50 D1244-D1254 (2022)
  16. A Comprehensive Pan-cancer Analysis of the Biological Immunomodulatory Function and Clinical Value of CD27. Wang Y, Guan L, Zhao Y, Yang Y, Wang Y, Feng S, Zou A, Li Y, Zhou B, Zhang D, Che W, Liu F. J Cancer 15 508-525 (2024)
  17. A dynamic biomimetic model of the membrane-bound CD4-CD3-TCR complex during pMHC disengagement. Rollins ZA, Faller R, George SC. Biophys J 122 3133-3145 (2023)
  18. A new cell line based coculture system for skin sensitisation testing in one single assay using T cells, aryl hydrocarbon receptor knockout, and co-inhibitory blockage. Sonnenburg A, Stahlmann R, Kreutz R, Peiser M. Arch Toxicol 97 1677-1689 (2023)
  19. Analysis of Immune-Cell Distribution of Bone Marrow in Patients with Myelodysplastic Syndrome. Lin CL, Lin CC, Chen TT, Lo WJ, Tzeng SL. Hematol Rep 15 50-56 (2023)
  20. Anti-CD3 Antibody Treatment Reduces Scar Formation in a Rat Model of Myocardial Infarction. Wernly B, Paar V, Aigner A, Pilz PM, Podesser BK, Förster M, Jung C, Hofbauer JP, Tockner B, Wimmer M, Kraus T, Motloch LJ, Hackl M, Hoppe UC, Kiss A, Lichtenauer M. Cells 9 (2020)
  21. Antigen receptor repertoires of one of the smallest known vertebrates. Giorgetti OB, Shingate P, O'Meara CP, Ravi V, Pillai NE, Tay BH, Prasad A, Iwanami N, Tan HH, Schorpp M, Venkatesh B, Boehm T. Sci Adv 7 (2021)
  22. Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity. Sun Y, Yang XN, Yang SS, Lyu YZ, Zhang B, Liu KW, Li N, Cui JC, Huang GX, Liu CL, Xu J, Mi JQ, Chen Z, Fan XH, Chen SJ, Chen S. Signal Transduct Target Ther 8 445 (2023)
  23. Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation. Wauters AC, Scheerstra JF, Vermeijlen IG, Hammink R, Schluck M, Woythe L, Wu H, Albertazzi L, Figdor CG, Tel J, Abdelmohsen LKEA, van Hest JCM. ACS Nano 16 15072-15085 (2022)
  24. Atomic-resolution view of complete TCR-CD3 revealed. Chai J. Protein Cell 11 158-160 (2020)
  25. Benzo[a]pyrene Exposure Reduces Cell-Type Diversity and Stimulates Sex-Biased Damage Pathways in End Organs of Lupus-Prone Mice. Zhu R, Kennicott K, Liang Y. Int J Mol Sci 24 6163 (2023)
  26. CAR T cells: from tinkering to rational design. Malissen B. Cell Res 30 948-949 (2020)
  27. Differences of blood cells, lymphocyte subsets and cytokines in COVID-19 patients with different clinical stages: a network meta-analysis. Yan W, Chen D, Bigambo FM, Wei H, Wang X, Xia Y. BMC Infect Dis 21 156 (2021)
  28. Discovering immunoreceptor coupling and organization motifs. Reth M. Front Immunol 14 1253412 (2023)
  29. Early neonatal complications in pregnant women with gestational diabetes mellitus and the effects of glycemic control on neonatal infection. Wang BB, Xue M. World J Diabetes 14 1393-1402 (2023)
  30. Effect of Systemic Administration of CD4+ T cells and Local Administration of T-cell Stimulants on T-cell Activity in Psoriatic Skin Xenografts on NOG Mice. Christensen PK, Hansen AK, Skov S, Larsen J, Høyer-Hansen MH, Koch J. Comp Med 73 285-293 (2023)
  31. Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer. Lidström T, Cumming J, Gaur R, Frängsmyr L, Pateras IS, Mickert MJ, Franklin O, Forsell MNE, Arnberg N, Dongre M, Patthey C, Öhlund D. Cancer Immunol Res 11 72-92 (2023)
  32. Functional integration of protein A binding ability to antibody fragments for convenient and tag-free purification. Kuwahara A, Nazuka M, Kuroki Y, Ito K, Watanabe S, Kumagai I, Asano R. Bioengineered 14 2259093 (2023)
  33. HLA-II immunopeptidome profiling and deep learning reveal features of antigenicity to inform antigen discovery. Stražar M, Park J, Abelin JG, Taylor HB, Pedersen TK, Plichta DR, Brown EM, Eraslan B, Hung YM, Ortiz K, Clauser KR, Carr SA, Xavier RJ, Graham DB. Immunity 56 1681-1698.e13 (2023)
  34. Histochemical Comparison of Human and Rat Lacrimal Glands: Implications for Bio-Engineering Studies. Wood JPM, Chidlow G, Halliday LA, Casson RJ, Selva D, Sun M. Transl Vis Sci Technol 11 10 (2022)
  35. Histopathological, Immunohistochemical and Biochemical Studies of Murine Hepatosplenic Tissues Affected by Chronic Toxoplasmosis. Yahia SH, Etewa SE, Saleh NS, Mohammad SM, Aboulfotouh NI, Kandil AM, Sarhan MH. J Parasitol Res 2022 2165205 (2022)
  36. Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo model. Zorn JA, Wheeler ML, Barnes RM, Kaberna J, Morishige W, Harris M, Huang RY, Lohre J, Chang YC, Chau B, Powers K, Schindler I, Neradugomma N, Thomas W, Liao X, Zhou Y, West SM, Wang F, Kotapati S, Chen G, Yamazoe S, Kosenko A, Dollinger G, Sproul T, Rajpal A, Strop P. Sci Rep 12 3530 (2022)
  37. Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination. Paniskaki K, Anft M, Meister TL, Marheinecke C, Pfaender S, Skrzypczyk S, Seibert FS, Thieme CJ, Konik MJ, Dolff S, Anastasiou O, Holzer B, Dittmer U, Queren C, Fricke L, Rohn H, Westhoff TH, Witzke O, Stervbo U, Roch T, Babel N. Front Immunol 13 816220 (2022)
  38. Immune-Enhancing Effect of Sargassum horneri on Cyclophosphamide-Induced Immunosuppression in BALB/c Mice and Primary Cultured Splenocytes. Kim HI, Kim DS, Jung Y, Sung NY, Kim M, Han IJ, Nho EY, Hong JH, Lee JK, Boo M, Kim HL, Baik S, Jung KO, Lee S, Kim CS, Park J. Molecules 27 8253 (2022)
  39. Inhibition of lysophosphatidic acid receptor 1-3 deteriorates experimental autoimmune encephalomyelitis by inducing oxidative stress. Choi JH, Oh J, Lee MJ, Bae H, Ko SG, Nah SY, Cho IH. J Neuroinflammation 18 240 (2021)
  40. MHC Restriction: Where Are We Now? Zareie P, Farenc C, La Gruta NL. Viral Immunol. 33 179-187 (2020)
  41. Mini-TCRs: Truncated T cell receptors to generate T cells from induced pluripotent stem cells. Takayanagi SI, Wang B, Hasegawa S, Nishikawa S, Fukumoto K, Nakano K, Chuganji S, Kato Y, Kamibayashi S, Minagawa A, Kunisato A, Nozawa H, Kaneko S. Mol Ther Methods Clin Dev 31 101109 (2023)
  42. Molecular Dynamics Simulations of Immune Receptors and Ligands. Pandey PR, Rózycki B, Weikl TR. Methods Mol Biol 2654 51-59 (2023)
  43. Molecular profiling of the intestinal mucosa and immune cells of the colon by multi-parametric histological techniques. Zadka Ł, Chrabaszcz K, Buzalewicz I, Wiercigroch E, Glatzel-Plucińska N, Szleszkowski Ł, Gomułkiewicz A, Piotrowska A, Kurnol K, Dzięgiel P, Jurek T, Malek K. Sci Rep 11 11309 (2021)
  44. Multiresolution 3D Optical Mapping of Immune Cell Infiltrates in Mouse Asthmatic Lung. Wu YC, Moon HG, Bindokas VP, Phillips EH, Park GY, Lee SS. Am J Respir Cell Mol Biol 69 13-21 (2023)
  45. Nasopharyngeal Carcinoma Subtype Discovery via Immune Cell Scores from Tumor Microenvironment. Sun Y, Liu Y, Chu H. J Immunol Res 2023 2242577 (2023)
  46. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS). Hashemian SM, Shafigh N, Afzal G, Jamaati H, Tabarsi P, Marjani M, Malekmohammad M, Mortazavi SM, Khoundabi B, Mansouri D, Moniri A, Hajifathali A, Roshandel E, Mortaz E, Adcock IM. Pulmonology (2020)
  47. Pre-T cell receptor localization and trafficking are independent of its signaling. Smid AI, Garforth SJ, Obaid MS, Bollons HR, James JR. J Cell Biol 222 e202212106 (2023)
  48. Recognition of Semaphorin Proteins by P. sordellii Lethal Toxin Reveals Principles of Receptor Specificity in Clostridial Toxins. Lee H, Beilhartz GL, Kucharska I, Raman S, Cui H, Lam MHY, Liang H, Rubinstein JL, Schramek D, Julien JP, Melnyk RA, Taipale M. Cell 182 345-356.e16 (2020)
  49. Self-programmed dynamics of T cell receptor condensation. Chen H, Xu X, Hu W, Wu S, Xiao J, Wu P, Wang X, Han X, Zhang Y, Zhang Y, Jiang N, Liu W, Lou C, Chen W, Xu C, Lou J. Proc Natl Acad Sci U S A 120 e2217301120 (2023)
  50. Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors. Wu D, Kolesnikov A, Yin R, Guest JD, Gowthaman R, Shmelev A, Serdyuk Y, Dianov DV, Efimov GA, Pierce BG, Mariuzza RA. Nat Commun 13 19 (2022)
  51. Structure-based engineering of a novel CD3ε-targeting antibody for reduced polyreactivity. Liu CY, Ahonen CL, Brown ME, Zhou L, Welin M, Krauland EM, Pejchal R, Widboom PF, Battles MB. MAbs 15 2189974 (2023)
  52. Case Reports Surgical, Dermatological and Morphopathological Considerations in the Diagnosis and Treatment of Cutaneous Lymphoproliferative Tumors, Primary CD4. Ardeleanu V, Moroianu LA, Sava A, Tebeica T, Jecan RC, Moroianu M, Tatu AL. Medicina (Kaunas) 58 1618 (2022)
  53. T Cell Receptor Repertoire Analysis Reveals Signatures of T Cell Responses to Human Mycobacterium tuberculosis. Shao MM, Yi FS, Huang ZY, Peng P, Wu FY, Shi HZ, Zhai K. Front Microbiol 13 829694 (2022)
  54. TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival. Freudenstein D, Litchfield C, Caramia F, Wright G, Solomon BJ, Ball D, Keam SP, Neeson P, Haupt Y, Haupt S. Cancers (Basel) 12 (2020)
  55. The TCR Cα Domain Regulates Responses to Self-pMHC Class II. Kim CY, Parrish HL, Kuhns MS. J Immunol 209 2033-2041 (2022)
  56. The establishment and application of CD3E humanized mice in immunotherapy. Zhang R, Zhang J, Zhou X, Zhao A, Yu C. Exp Anim 71 442-450 (2022)
  57. The role of the different CD3γ domains in TCR expression and signaling. Garcillán B, Megino RF, Herrero-Alonso M, Guardo AC, Perez-Flores V, Juraske C, Idstein V, Martin-Fernandez JM, Geisler C, Schamel WWA, Marin AV, Regueiro JR. Front Immunol 13 978658 (2022)
  58. Transcriptome analysis of porcine PBMCs reveals lipopolysaccharide-induced immunomodulatory responses and crosstalk of immune and glucocorticoid receptor signaling. Li Z, Trakooljul N, Hadlich F, Ponsuksili S, Wimmers K, Murani E. Virulence 12 1808-1824 (2021)
  59. Trapping or slowing the diffusion of T cell receptors at close contacts initiates T cell signaling. Chen KY, Jenkins E, Körbel M, Ponjavic A, Lippert AH, Santos AM, Ashman N, O'Brien-Ball C, McBride J, Klenerman D, Davis SJ. Proc Natl Acad Sci U S A 118 e2024250118 (2021)
  60. Tumor heterogeneity and immune-evasive T follicular cell lymphoma phenotypes at single-cell resolution. Suma S, Suehara Y, Fujisawa M, Abe Y, Hattori K, Makishima K, Sakamoto T, Sawa A, Bando H, Kaji D, Sugio T, Kato K, Akashi K, Matsue K, Carreras J, Nakamura N, Suzuki A, Suzuki Y, Ito K, Shiiba H, Chiba S, Sakata-Yanagimoto M. Leukemia (2023)


Quick links